Secaucus, NJ (PRWEB) May 2, 2006
“New garlic technology may have an enormous impact upon health challenges faced by the world today, including antibiotic resistance, influenza epidemics, biological threats, weight control, chronic disease, and even have an impact upon strategic military manpower in the field,” says Bill Sardi, president of Knowledge of Health, Inc., speaking at the International Supplyside East Conference at Meadowlands Exposition Center in Secaucus, New Jersey today.
With an increasing awareness that microscopic organisms may be the cause of some or all disease, and the realization that germs have mutated and now resist most modern antibiotics, there is concern that old diseases will once again sweep the earth as they once did prior to the antibiotic era which began in the 1930s.
“It’s interesting to note, that while Alexander Fleming was credited with his observation the penicillin mold killed bacteria in a laboratory dish in the 1920s, Louis Pasteur made a similar discovery with macerated garlic 60 years earlier. To date, antibiotic resistance has never been observed with allicin, garlic’s primary active ingredient,” says Sardi.
In an experiment conducted in 1977 it was shown that garlic is superior to the germ killing action of most mycin, cillin and cycline antibiotics. The question has always been how to make an effective pill out of garlic powder.
A fresh clove of garlic macerated in a hand press will yield about 5250 micrograms of allicin, but allicin is a transient molecule that cannot be released in garlic powders, only from fresh crushed cloves. Two components of garlic must mix together when garlic powder enters the stomach. An enzyme called allinase must mix with alliin, in order to form allicin. But stomach acid quickly destroys allinase and little or no allicin is produced.
“Enteric coated capsules attempt to get garlic pills to pass into the less acidic intestines where some allicin can be produced. Some of these pills pass all the way through the digestive tract without the dissolution of the coating,” says Sardi.
A newer type of garlic powder is buffered against stomach acid and has, for the first time in a human study, been shown to produce real allicin, as much as produced by a fresh crushed clove of garlic. This was not easy to prove since allicin cannot be detected in blood or urine samples. But in an advanced breath test developed by researchers at Plant Bioactives Research Institute in Orem, Utah, that works much like an alcohol breath test used by law enforcement, showed that a 600-milligram buffered garlic capsule produces more allicin than a clove of garlic.
“This achievement is long awaited, and may rival the discoveries made by Pasteur and Fleming,” says Sardi.
“Imagine a world with a garlic pill that can deliver real allicin,” says Sardi. He delivered a list of possibilities.
Sardi says manufacturers of garlic pills that deliver real allicin will have to perform human clinical tests so this new type of garlic pill can be used to treat or prevent disease, since labels on dietary supplements cannot make these claims. “But savvy consumers can take real allicin pills for good health,” says Sardi.
Sardi says consumers may be confused by labels on garlic pills that claim they deliver or yield allicin. He says the labels refer to tests performed in water in a laboratory dish, not the acidic environment of the human digestive tract. He suggests consumers ask garlic pill manufacturers to show their products release real allicin as demonstrated in the human breath test recently developed by the laboratory in Utah.
###